APRE: Aprea Therapeutics, Inc. Stock

by  •  • Comments Off on APRE: Aprea Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 27.75
Enterprise Value ($M) 7.45
Book Value ($M) 18.26
Book Value / Share 3.36
Price / Book 1.52
NCAV ($M) 18.14
NCAV / Share 3.34
Price / NCAV 1.53

Profitability (mra)
Return on Invested Capital (ROIC) -0.78
Return on Assets (ROA) -0.45
Return on Equity (ROE) -0.51

Liquidity (mrq)
Quick Ratio 5.14
Current Ratio 5.14

Balance Sheet (mrq) ($M)
Current Assets 22.52
Assets 22.65
Liabilities 4.39
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.58
Operating Income -15.47
Net Income -14.29
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -12.18
Cash from Investing -0.09
Cash from Financing 5.14

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G Sio Capital Management, LLC 7.49
02-07 13G/A Hirschman Orin 9.40 1.25

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-30 1,409 14,862 9.48
2024-04-29 119 434 27.42
2024-04-26 108 1,610 6.71

(click for more detail)

Similar Companies
ANEB – Anebulo Pharmaceuticals, Inc. ANIX – Anixa Biosciences, Inc.
APM – Aptorum Group Limited APTO – Aptose Biosciences Inc.
APVO – Aptevo Therapeutics Inc.


Financial data and stock pages provided by
Fintel.io